Epilepsy, Nocturnal Frontal Lobe, Type 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation.
|
14623738 |
2003 |
Epilepsy, Nocturnal Frontal Lobe, Type 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation.
|
14623738 |
2003 |
Epilepsy, Nocturnal Frontal Lobe, Type 1
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation.
|
14623738 |
2003 |
Epilepsy, Nocturnal Frontal Lobe, Type 1
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy.
|
10563623 |
1999 |
Epilepsy, Nocturnal Frontal Lobe, Type 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2.
|
7647781 |
1995 |
Epilepsy, Nocturnal Frontal Lobe, Type 1
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.
|
7550350 |
1995 |
Epilepsy, Nocturnal Frontal Lobe, Type 1
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)
|
0.500 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation.
|
14623738 |
2003 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.
|
7550350 |
1995 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
|
|
|
Seizures
|
0.440 |
Biomarker
|
phenotype |
CTD_human |
Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors.
|
16339034 |
2005 |
Seizures
|
0.440 |
Biomarker
|
phenotype |
CTD_human |
Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors.
|
10942032 |
2000 |
Seizures, Focal
|
0.420 |
Biomarker
|
phenotype |
CTD_human |
Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors.
|
16339034 |
2005 |
Seizures, Focal
|
0.420 |
Biomarker
|
phenotype |
CTD_human |
Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors.
|
10942032 |
2000 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
The present study suggests that the α(4)β(2) nAChR agonists may be better suited to control the epigenetic alterations of GABAergic neurons in schizophrenia than the α(7) nAChR agonists.
|
21368748 |
2011 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Expression of the α7*nAChR mRNA and protein are reduced in multiple regions of post-mortem brain from patients diagnosed with schizophrenia.
|
21979958 |
2011 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
α7 nicotinic receptor agonism mitigates phencyclidine-induced changes in synaptophysin and Arc gene expression in the mouse prefrontal cortex.
|
20817066 |
2010 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Together, these results suggest that the molecular mechanism of the association between NRG1 risk alleles and schizophrenia may include down-regulation of nAChR alpha7 expression.
|
17884806 |
2007 |
Epilepsy, Frontal Lobe
|
0.400 |
Biomarker
|
disease |
CTD_human |
Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation.
|
17881519 |
2007 |
Epilepsy, Frontal Lobe
|
0.400 |
Biomarker
|
disease |
CTD_human |
Mice lacking neuronal nicotinic acetylcholine receptor beta4-subunit and mice lacking both alpha5- and beta4-subunits are highly resistant to nicotine-induced seizures.
|
14996991 |
2004 |
Epilepsy, Frontal Lobe
|
0.400 |
Biomarker
|
disease |
CTD_human |
A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.
|
12823585 |
2003 |
Attention deficit hyperactivity disorder
|
0.370 |
Biomarker
|
disease |
CTD_human |
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.
|
21748252 |
2012 |
Mental Depression
|
0.340 |
Biomarker
|
disease |
PSYGENET |
We identified a significant epistasis effect BCL1 by CHRNA4 showing that carriers of the CC genotype at the BCL1 locus who were also homozygous for the T allele at the CHRNA4 locus had the highest depression scores.
|
22760121 |
2012 |
Mental Depression
|
0.340 |
Biomarker
|
disease |
PSYGENET |
Study findings identified a significant link between the CHRNA4:rs1044396 polymorphism and depression and loneliness in the aged.
|
22008229 |
2012 |
Depressive disorder
|
0.340 |
Biomarker
|
disease |
PSYGENET |
We identified a significant epistasis effect BCL1 by CHRNA4 showing that carriers of the CC genotype at the BCL1 locus who were also homozygous for the T allele at the CHRNA4 locus had the highest depression scores.
|
22760121 |
2012 |